Patel P, Mukai D, Wilson A F
Department of Medicine, University of California, Irvine, Medical Center, Orange 92668.
Am Rev Respir Dis. 1990 Feb;141(2):357-60. doi: 10.1164/ajrccm/141.2.357.
The dose-response effect of monodispersed isoproterenol of two different sizes (diameters 2.5 and 5 microns) was examined in eight mild asthmatic subjects (baseline FEV, 81.5% of predicted). Pulmonary and cardiovascular variables were measured before and following 1, 2, 4, 8, and 16 cumulative min of aerosol inhalation. Subjects inhaled 1 to 30 micrograms (2.5-microns particles) or 2 to 50 micrograms (5-microns particles) of isoproterenol. Pulmonary but not cardiac responses were significantly greater for the 2.5-microns particles as compared to equivalent doses of 5-microns particles. Pulmonary dose-related response differences were particularly marked for variables associated with small airway function (FEF25-75 and FEF75-85). These findings suggest that small particles penetrate more deeply into the lung and thereby more effectively dilate small airways and that small amounts of appropriately sized inhaled bronchodilator may produce considerable therapeutic effects.
在八名轻度哮喘患者(基线第一秒用力呼气量[FEV₁]为预测值的81.5%)中,研究了两种不同大小(直径2.5微米和5微米)的单分散异丙肾上腺素的剂量反应效应。在累积吸入气雾剂1、2、4、8和16分钟之前和之后,测量肺部和心血管变量。受试者吸入1至30微克(2.5微米颗粒)或2至50微克(5微米颗粒)的异丙肾上腺素。与等量的5微米颗粒相比,2.5微米颗粒引起的肺部反应而非心脏反应明显更大。对于与小气道功能相关的变量(25%至75%用力呼气流量[FEF₂₅₋₇₅]和75%至85%用力呼气流量[FEF₇₅₋₈₅]),肺部剂量相关的反应差异尤为明显。这些发现表明,小颗粒可更深入地渗透到肺部,从而更有效地扩张小气道,并且少量大小合适的吸入性支气管扩张剂可能产生相当大的治疗效果。